DANAHER CORPORATION's ticker is DHR and the CUSIP is 235851102. A total of 884 filers reported holding DANAHER CORPORATION in Q4 2013. The put-call ratio across all filers is 0.40 and the average weighting 0.5%.
About DANAHER CORPORATION
Danaher Corporation is a global science and technology company that designs, manufactures, and markets innovative products and services to professional, medical, industrial, and commercial customers. The company operates through four segments: Life Sciences, Diagnostics, Dental, and Environmental & Applied Solutions.
Danaher's Life Sciences segment provides a range of research tools to scientists around the world, including mass spectrometry, chromatography, and automation systems. The Diagnostics segment offers a broad range of diagnostic products, including clinical chemistry, immunoassay, microbiology, and molecular diagnostic systems. The Dental segment provides a range of dental equipment and consumables, including imaging systems, dental instruments, and consumables. The Environmental & Applied Solutions segment offers a range of products and services to help customers protect the environment and improve productivity.
Danaher has a strong track record of growth and innovation, driven by its focus on continuous improvement and customer satisfaction. The company has a culture of operational excellence, which has enabled it to consistently deliver high-quality products and services to its customers. Danaher's management team is highly experienced and has a proven track record of creating value for shareholders.
In conclusion, Danaher Corporation is a well-established and innovative company that is well-positioned to continue delivering strong growth and value to its shareholders. With its focus on operational excellence and customer satisfaction, Danaher is a company that investors should keep an eye on.
It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $16,605,838 | +49.0% | 66,932 | +44.2% | 0.10% | +36.4% |
| Q2 2023 | $11,143,083 | -9.4% | 46,430 | -4.9% | 0.08% | -15.4% |
| Q1 2023 | $12,300,435 | -2.9% | 48,804 | +2.3% | 0.09% | -11.7% |
| Q4 2022 | $12,664,422 | +152.0% | 47,715 | +145.2% | 0.10% | +66.1% |
| Q3 2022 | $5,025,000 | -1.7% | 19,456 | -3.5% | 0.06% | -6.1% |
| Q2 2022 | $5,112,000 | +2.4% | 20,161 | +18.5% | 0.07% | +8.2% |
| Q1 2022 | $4,991,000 | +4.6% | 17,015 | +17.3% | 0.06% | +5.2% |
| Q4 2021 | $4,772,000 | +7.6% | 14,503 | -0.5% | 0.06% | -3.3% |
| Q3 2021 | $4,436,000 | +8.9% | 14,572 | -4.0% | 0.06% | +5.3% |
| Q2 2021 | $4,072,000 | +62.2% | 15,175 | +36.1% | 0.06% | +7.5% |
| Q1 2021 | $2,510,000 | +10.0% | 11,151 | +8.6% | 0.05% | 0.0% |
| Q4 2020 | $2,281,000 | +7.3% | 10,269 | +4.0% | 0.05% | -3.6% |
| Q3 2020 | $2,125,000 | +24.2% | 9,870 | +2.0% | 0.06% | +19.6% |
| Q2 2020 | $1,711,000 | +29.7% | 9,674 | +1.5% | 0.05% | +4.5% |
| Q1 2020 | $1,319,000 | -10.0% | 9,532 | -0.1% | 0.04% | +12.8% |
| Q4 2019 | $1,465,000 | +10.7% | 9,545 | +3.7% | 0.04% | -2.5% |
| Q3 2019 | $1,323,000 | +10.3% | 9,205 | +9.6% | 0.04% | +8.1% |
| Q2 2019 | $1,199,000 | +14.0% | 8,401 | +5.4% | 0.04% | +8.8% |
| Q1 2019 | $1,052,000 | +4.7% | 7,968 | -18.5% | 0.03% | -12.8% |
| Q4 2018 | $1,005,000 | -3.1% | 9,777 | +2.1% | 0.04% | +8.3% |
| Q3 2018 | $1,037,000 | +38.6% | 9,576 | +25.9% | 0.04% | -2.7% |
| Q2 2018 | $748,000 | +0.7% | 7,608 | +0.1% | 0.04% | +12.1% |
| Q1 2018 | $743,000 | +2.3% | 7,597 | -3.0% | 0.03% | +10.0% |
| Q4 2017 | $726,000 | +5.7% | 7,832 | -2.3% | 0.03% | -3.2% |
| Q3 2017 | $687,000 | -26.5% | 8,017 | -27.7% | 0.03% | -29.5% |
| Q2 2017 | $935,000 | -7.6% | 11,092 | -6.0% | 0.04% | -8.3% |
| Q1 2017 | $1,012,000 | +5.5% | 11,804 | -3.9% | 0.05% | -4.0% |
| Q4 2016 | $959,000 | -27.5% | 12,278 | -27.2% | 0.05% | 0.0% |
| Q3 2016 | $1,322,000 | +20.6% | 16,860 | +55.4% | 0.05% | -21.9% |
| Q2 2016 | $1,096,000 | +3.7% | 10,849 | -3.2% | 0.06% | -3.0% |
| Q1 2016 | $1,057,000 | +17.7% | 11,211 | +16.1% | 0.07% | +15.8% |
| Q4 2015 | $898,000 | +12.8% | 9,654 | +3.7% | 0.06% | +5.6% |
| Q3 2015 | $796,000 | +15.9% | 9,310 | +14.7% | 0.05% | +22.7% |
| Q2 2015 | $687,000 | 0.0% | 8,115 | 0.0% | 0.04% | 0.0% |
| Q1 2015 | $687,000 | +7.8% | 8,115 | +9.6% | 0.04% | -2.2% |
| Q4 2014 | $637,000 | +19.3% | 7,404 | +5.2% | 0.04% | +25.0% |
| Q3 2014 | $534,000 | +14.1% | 7,041 | +19.0% | 0.04% | +16.1% |
| Q2 2014 | $468,000 | +34.5% | 5,918 | +27.9% | 0.03% | +24.0% |
| Q1 2014 | $348,000 | +32.3% | 4,626 | +34.9% | 0.02% | +25.0% |
| Q4 2013 | $263,000 | +20.1% | 3,430 | +8.8% | 0.02% | +5.3% |
| Q3 2013 | $219,000 | +6.8% | 3,152 | -5.0% | 0.02% | -9.5% |
| Q1 2013 | $205,000 | – | 3,317 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARTHUR M. COHEN & ASSOCIATES, LLC | 232,593 | $60,115,000 | 16.52% |
| Defender Capital, LLC. | 139,231 | $35,988,000 | 14.10% |
| Third Point | 2,700,000 | $697,383,000 | 12.60% |
| Riverstone Advisors, LLC | 62,416 | $16,121,000 | 10.38% |
| Eos Focused Equity Management, L.P. | 32,304 | $8,344,000 | 9.87% |
| Alphinity Investment Management Pty Ltd | 1,185,235 | $306,134,000 | 9.81% |
| AGF Investments America Inc. | 88,205 | $22,782,000 | 8.41% |
| Front Street Capital Management, Inc. | 117,802 | $30,427,000 | 7.70% |
| CORTLAND ASSOCIATES INC/MO | 164,142 | $42,396,000 | 7.55% |
| THAMES CAPITAL MANAGEMENT LLC | 57,156 | $14,763,000 | 7.33% |